128 related articles for article (PubMed ID: 6741865)
1. Phase II clinical evaluation of AZQ in adenocarcinoma of the lung.
Decker DA; Samson MK; Haas CD; Baker LH
Am J Clin Oncol; 1984 Aug; 7(4):353-5. PubMed ID: 6741865
[TBL] [Abstract][Full Text] [Related]
2. Phase II clinical evaluation of AZQ in renal cell carcinoma.
Decker DA; Kish J; Al-Sarraf M; Goldfarb S
Am J Clin Oncol; 1986 Apr; 9(2):126-8. PubMed ID: 3717078
[TBL] [Abstract][Full Text] [Related]
3. Phase II study of diaziquone in patients with advanced carcinoma of the lung.
Frytak S; Eagan RT; Creagan ET; Nichols WC
Cancer Treat Rep; 1984 Sep; 68(9):1193-4. PubMed ID: 6478455
[No Abstract] [Full Text] [Related]
4. Treatment of metastatic breast cancer with AZQ: a phase II trial.
Martino S; Ratanatharathorn V; Samal BA; Singhakowinta A; Haas C
Cancer Invest; 1988; 6(3):289-91. PubMed ID: 3167612
[TBL] [Abstract][Full Text] [Related]
5. Phase II trial of diaziquone (AZQ) in advanced malignant melanoma.
Høst H; Joss R; Pinedo H; Bruntsch U; Cavalli F; Renard G; van Glabbeke M; Rozencweig M
Eur J Cancer Clin Oncol; 1983 Feb; 19(2):295-8. PubMed ID: 6681775
[TBL] [Abstract][Full Text] [Related]
6. Phase II trial of aziridinylbenzoquinone (AZQ) in patients with refractory small cell carcinoma of the lung.
Fuks JZ; Aisner J; Van Echo DA; Levitt M; Ihde DC; Carney D; Wiernik PH
Am J Clin Oncol; 1983 Apr; 6(2):171-3. PubMed ID: 6299094
[TBL] [Abstract][Full Text] [Related]
7. Phase II study of aziridinylbenzoquinone (AZQ: NSC-182986) in the treatment of malignant gliomas recurrent after radiation. Preliminary report.
Decker DA; Al Sarraf M; Kresge C; Austin D; Wilner HI
J Neurooncol; 1985; 3(1):19-21. PubMed ID: 2987424
[TBL] [Abstract][Full Text] [Related]
8. Phase II study of diaziquone in untreated advanced gastric carcinoma. A Southwest Oncology Group Study.
Pugh RP; Fleming T; Guy JT; Weick JK; Ward JH
Am J Clin Oncol; 1989 Feb; 12(1):11-3. PubMed ID: 2912017
[TBL] [Abstract][Full Text] [Related]
9. Phase I-II evaluation of intra-arterial diaziquone for recurrent malignant astrocytomas.
Greenberg HS; Ensminger WD; Layton PB; Gebarski S; Meyer M; Chaffee B; Bender JF; Grillo-Lopez AJ
Cancer Treat Rep; 1986 Mar; 70(3):353-7. PubMed ID: 3006913
[TBL] [Abstract][Full Text] [Related]
10. Phase I study of diaziquone.
Frytak S; Eagan RT; Ames MM; Creagan ET; Nichols WC
Cancer Treat Rep; 1984; 68(7-8):975-8. PubMed ID: 6744349
[TBL] [Abstract][Full Text] [Related]
11. High dose AZQ in renal cancer. A Southwest Oncology Group phase II study.
Stephens RL; Kirby R; Crawford ED; Bukowski R; Rivkin SE; O'Bryan RM
Invest New Drugs; 1986; 4(1):57-9. PubMed ID: 3700042
[TBL] [Abstract][Full Text] [Related]
12. Phase II trial of aziridinylbenzoquinone (AZQ) in patients with refractory lymphoma.
McLaughlin P; Cabanillas F; Bedikian AY; Bodey GP
Cancer Treat Rep; 1983 May; 67(5):507-8. PubMed ID: 6850666
[No Abstract] [Full Text] [Related]
13. Phase II clinical trial of diaziquone in bronchogenic carcinoma.
Chiuten DF; Umsawasdi T; Dhingra HM; Murphy WK; Spitzer G; Carr DT; Bodey GP; Valdivieso M
Cancer Treat Rep; 1985; 69(7-8):921-2. PubMed ID: 4016800
[No Abstract] [Full Text] [Related]
14. Cancer and leukemia group B phase II non-small cell lung carcinoma trial: aziridinylbenzoquinone (AZQ).
Carey RW; Comis RL; Anbar D; Kennedy BJ; Capizzi RL; Shulman P; Booth BW; Green M; Raich PC
Cancer Treat Rep; 1983 Jan; 67(1):95-6. PubMed ID: 6616498
[No Abstract] [Full Text] [Related]
15. Response rate and toxicity with aziridinylbenzoquinone in patients with recurrent gliomas. A progress report.
Tapazoglou E; Kish J; Ensley J; Al-Sarraf M
Am J Clin Oncol; 1988 Aug; 11(4):474-8. PubMed ID: 3407628
[TBL] [Abstract][Full Text] [Related]
16. A phase II clinical trial of diaziquone (AZQ) in the treatment of patients with recurrent adenocarcinoma and adenosquamous carcinoma of the cervix. A Gynecologic Oncology Group study.
Slayton RE; Blessing JA; Rettenmaier M; Ball H
Invest New Drugs; 1989 Nov; 7(4):337-40. PubMed ID: 2599803
[TBL] [Abstract][Full Text] [Related]
17. A phase I/II study of 24 hour intravenous AZQ in recurrent primary brain tumors.
Chamberlain MC; Prados MD; Silver P; Levin VA
J Neurooncol; 1988 Dec; 6(4):319-23. PubMed ID: 3221259
[TBL] [Abstract][Full Text] [Related]
18. Phase II study of diaziquone in advanced soft tissue and bony sarcoma: a Southwest Oncology Group study.
Zidar BL; Baker LH; Rivkin SE; Balcerzak SP; Stephens RL
Cancer Treat Rep; 1985 Sep; 69(9):1035-6. PubMed ID: 4028037
[No Abstract] [Full Text] [Related]
19. Phase II clinical evaluation of AZQ in metastatic breast cancer.
Yap HY; Bedikian AY; Schell FC; Blumenschein GR; Bodey GP
Am J Clin Oncol; 1983 Feb; 6(1):31-3. PubMed ID: 6837505
[TBL] [Abstract][Full Text] [Related]
20. A phase II study of aziridinylbenzoquinone (AZQ) in advanced large bowel carcinoma.
Rubin J; van Hazel GA; Schutt AJ; Moertel CG; O'Connell MJ
Am J Clin Oncol; 1982 Oct; 5(5):539-40. PubMed ID: 7180832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
